发布时间:2024/5/2 8:03:58 阅读人数:11
MCE 站:Rezvilutamide
CAS:1572045-62-5
品牌:MedChemExpress (MCE)
存储条件:Powder: -20°C, 3 years; 4°C, 2 years.In solvent: -80°C, 6 months; -20°C, 1 month.
生物活性: Rezvilutamide (SHR3680) 是一种雄激素受体拮抗剂。 Rezvilutamide (SHR3680) 用于前列腺癌的研究
[1]
[2]。
热销产品:Nobiletin | Favipiravir | DSPE-PEG2000-Maleimide | Ivosidenib | C16-Ceramide | Siltuximab | 9-cis-Retinoic acid | VER-155008 | D18 | GYY4137
研究领域:Vitamin D Related/Nuclear Receptor
作用靶点:Androgen Receptor
热门产品线:重组蛋白 | 化合物库 | 天然产物 | 荧光染料 | PROTAC | 同位素标记物 | 寡核苷酸 Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Fluorescent Dye | PROTAC | Isotope-Labeled Compounds | Oligonucleotides 参考文献: 原创作者:MedChemExpress
[1]. SangjunYoo, et al. New drugs in prostate cancer. Prostate International Volume 4, Issue 2, June 2016, Pages 37-42.
[2]. Veronica Mollica, et al. Molecular Mechanisms Related to Hormone Inhibition Resistance in Prostate Cancer. Cells. 2019 Jan 11;8(1):43.
相关产品